title: Stability of the vasopressin V2 receptor-adenylyl cyclase system in rat kidney.
abstract: In the Brattleboro rat with diabetes insipidus vasopressin V2 receptor mRNA and the mRNA of various adenylyl cyclase (AC) isoforms are moderately reduced compared with those of normal rats. In the present study renal vasopressin V2 receptor mRNA was modestly higher (by 34%), as was expression of AC 5, 6 and 9 mRNAs (up to 22% greater), in BDI rats treated with the vasopressin V2 receptor agonist desamino-[Arg8] vasopressin than in untreated controls. AC 4 mRNA was decreased by 17% following desamino-[Arg8s] vasopressin treatment. While the stimulatory Gsalpha mRNA was little affected by the desamino-[Arg8] vasopressin treatment, two of the inhibitory G proteins were raised (Galphai-2 by 54% and Galphai-3 by 57%). Treatment of Sprague-Dawley rats with a specific vasopressin V2 receptor antagonist (SR 121463A) was not associated with any marked changes in mRNA expression. These results indicate that the vasopressin V2 receptor adenylyl cyclase system mediating the antidiuretic response to vasopressin is relatively stable. The Gi proteins may be involved in the stabilizing mechanism.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, U-99, Hôpital Henri Mondor, Créteil, France.
authors.forename: T
authors.initials: T
authors.lastname: Shen
authors.forename: J
authors.initials: J
authors.lastname: Laycock
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
authors.forename: N
authors.initials: N
authors.lastname: Defer
authors.forename: J
authors.initials: J
authors.lastname: Hanoune
mesh_terms: D000262:Adenylyl Cyclases / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D015152:Blotting, Northern; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D015536:Down-Regulation; D019204:GTP-Binding Proteins / Q000235:genetics; D007668:Kidney / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D007671:Kidney Concentrating Ability; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011910:Rats, Brattleboro; D017207:Rats, Sprague-Dawley; D017483:Receptors, Vasopressin / Q000819:agonists / Q000502:physiology*; D012076:Renal Agents / Q000494:pharmacology; D012964:Sodium / Q000652:urine; D013141:Spiro Compounds / Q000494:pharmacology
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D009025:Morpholines; D012333:RNA, Messenger; D017483:Receptors, Vasopressin; D012076:Renal Agents; D013141:Spiro Compounds; D012964:Sodium; C103281:satavaptan; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D003894:Deamino Arginine Vasopressin; D011188:Potassium